phosphatidylcholines has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 4 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies ((9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one) | Trials ((9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one) | Recent Studies (post-2010) ((9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 3,082 | 1,154 | 431 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Black, M; Keyhani, K; Knight, V; Waldrep, JC | 1 |
| Koskinen, MO; Nieminen, MM; Saari, SM; Turjanmaa, VM; Vidgren, MT; Waldrep, JC | 1 |
| Koskinen, MO; Nieminen, MM; Saari, M; Turjanmaa, VM; Vidgren, MT | 1 |
| Ahmed, W; Albed Alhnan, M; Elhissi, A; Khan, I; Subramanian, S; Yousaf, S | 1 |
1 trial(s) available for phosphatidylcholines and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Adult; Aerosols; Anti-Asthmatic Agents; Beclomethasone; Cross-Over Studies; Drug Carriers; Female; Humans; Liposomes; Lung; Male; Middle Aged; Nebulizers and Vaporizers; Organotechnetium Compounds; Particle Size; Phosphatidylcholines; Technetium; Tissue Distribution | 1999 |
3 other study(ies) available for phosphatidylcholines and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
Operating characteristics of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol.
Topics: Aerosols; Beclomethasone; Chromatography, High Pressure Liquid; Drug Carriers; Equipment Design; Humans; Liposomes; Lung; Models, Biological; Mouth Breathing; Nebulizers and Vaporizers; Particle Size; Phosphatidylcholines; Pulmonary Ventilation; Residual Volume; Surface Properties; Tidal Volume | 1994 |
Regional lung deposition and clearance of 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma.
Topics: Administration, Inhalation; Adult; Aged; Anti-Asthmatic Agents; Asthma; Beclomethasone; Drug Carriers; Female; Forced Expiratory Volume; Gamma Cameras; Humans; Liposomes; Lung; Male; Middle Aged; Nebulizers and Vaporizers; Phosphatidylcholines; Radionuclide Imaging; Technetium | 1998 |
Proliposome tablets manufactured using a slurry-driven lipid-enriched powders: Development, characterization and stability evaluation.
Topics: Beclomethasone; Chemistry, Pharmaceutical; Cholesterol; Drug Carriers; Drug Stability; Hardness; Lipids; Liposomes; Mannitol; Particle Size; Phosphatidylcholines; Powders; Sorbitol; Tablets; Temperature | 2018 |